
Sign up to save your podcasts
Or


Key points:
This episode provides crucial insights into the evolving landscape of EU Health Technology Assessment (HTA) and the significant challenges ahead.
Stefan Walzer’s expertise sheds light on the pressures on pricing, clinical requirements, and the upcoming European Joint Clinical Assessment (JCA).
If you’re involved in the healthcare industry or have a keen interest in market access and health economics, this episode is a must-listen. Don’t keep these valuable insights to yourself—share this episode with your friends and colleagues who can benefit from understanding these pivotal developments.
Tune in now and join the conversation on shaping the future of healthcare in Europe.
By Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry4.4
99 ratings
Key points:
This episode provides crucial insights into the evolving landscape of EU Health Technology Assessment (HTA) and the significant challenges ahead.
Stefan Walzer’s expertise sheds light on the pressures on pricing, clinical requirements, and the upcoming European Joint Clinical Assessment (JCA).
If you’re involved in the healthcare industry or have a keen interest in market access and health economics, this episode is a must-listen. Don’t keep these valuable insights to yourself—share this episode with your friends and colleagues who can benefit from understanding these pivotal developments.
Tune in now and join the conversation on shaping the future of healthcare in Europe.

78,343 Listeners

32,090 Listeners

30,638 Listeners

43,570 Listeners

9,484 Listeners

496 Listeners

166 Listeners

341 Listeners

8,662 Listeners

6,062 Listeners

29,122 Listeners

19 Listeners

3,094 Listeners

10 Listeners

27 Listeners